Related Articles
Serious neutropenia following neoadjuvant chemotherapy for locally advanced breast cancer: A case report
A study of docetaxel weekly or every three weeks in combination with carboplatin as first line chemotherapy in epithelial ovarian cancer: Hematological and non-hematological toxicity profiles
Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Rationale for the use of gemcitabine in breast cancer (Review)